Bremen, December 19, 2012 - MeVis Medical Solutions AG [ISIN: DE000A0LBFE4], a leading provider of medical imaging software, has managed to reduce the payment of the last tranche for the acquisition of the 49 % stake in MBS KG from originally € 3.0 million to € 1.4 million in a constructive dialogue with Siemens on the interpretation of a contract term. This payment is due at the end of 2012. Furthermore, a license credit to be granted by MeVis until 2015 is reduced by approximately € 0.4 million. This results in an overall reduction of liabilities by approximately € 2.0 million which will be booked against goodwill thus having no impact on earnings.
On that basis and on the basis of the current business development the forecast for the current fiscal year will be adjusted:
- For 2012 consolidated sales now will be expected to be slightly lower compared to the previous year.
- Through sustainable cost reductions both in personnel costs as well as other operating expenses a significantly increased consolidated EBIT of at least € 2 million is expected.
- Even considering the purchase price payment, a positive cash flow will be expected for 2012.
The Annual Report 2012 and the forecast for the next fiscal year will be published in April 2013.